| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 154.16M | 147.79M | 126.97M | 127.37M | 100.75M | 82.65M |
| Gross Profit | 49.33M | 46.13M | 41.05M | 38.73M | 26.57M | 27.78M |
| EBITDA | 13.95M | 12.28M | 23.41M | 22.16M | 15.67M | 15.72M |
| Net Income | 712.00K | -2.75M | 9.24M | 10.01M | 4.38M | 7.16M |
Balance Sheet | ||||||
| Total Assets | 178.73M | 174.75M | 175.61M | 170.36M | 159.38M | 158.22M |
| Cash, Cash Equivalents and Short-Term Investments | 8.26M | 10.53M | 6.29M | 10.59M | 8.05M | 8.50M |
| Total Debt | 37.32M | 43.56M | 37.86M | 38.41M | 42.40M | 44.10M |
| Total Liabilities | 60.74M | 65.39M | 59.85M | 60.82M | 61.60M | 63.85M |
| Stockholders Equity | 117.99M | 109.36M | 115.76M | 109.54M | 97.78M | 94.38M |
Cash Flow | ||||||
| Free Cash Flow | 19.70M | 11.35M | -702.00K | 14.03M | 3.83M | -1.85M |
| Operating Cash Flow | 32.39M | 25.00M | 7.78M | 21.12M | 10.90M | 10.86M |
| Investing Cash Flow | -13.30M | -13.34M | -8.29M | -7.09M | -6.98M | -13.29M |
| Financing Cash Flow | -18.70M | -7.41M | -3.73M | -11.53M | -4.34M | 3.72M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £562.74M | 20.24 | 6.22% | 9.55% | 0.58% | 61.53% | |
64 Neutral | £941.08M | -16.67 | 3.37% | 1.35% | -11.78% | -92.61% | |
63 Neutral | £281.11M | 30.43 | 3.48% | 2.38% | -4.71% | 86.21% | |
62 Neutral | £188.32M | 268.06 | 0.60% | 1.97% | 15.56% | -92.94% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | £3.55B | -27.81 | -5.62% | 3.64% | -4.60% | -126.46% | |
51 Neutral | £97.64M | -1.20 | -7.26% | ― | -4.41% | 2.29% |
Zotefoams has acquired Overseas Konstellation Company S.A. (OKC), a Spanish producer of technical foams, for up to €36.0m. This acquisition enhances Zotefoams’ product portfolio, market reach, and manufacturing capabilities, aligning with its strategy to expand beyond its core business. OKC’s expertise in foam recycling and its established presence in European markets will support Zotefoams’ growth ambitions and strategic priorities, including moving up the value chain and achieving broader geographic balance. The acquisition is expected to be earnings accretive in its first year and offers immediate cross-selling opportunities.
Zotefoams plc announced a transaction involving its Group CEO, Ronan Michael Cox, who acquired partnership shares and was awarded matching shares under the company’s Share Incentive Plan. This transaction, conducted in accordance with the UK Market Abuse Regulation, reflects the company’s ongoing commitment to aligning management interests with shareholder value.
Zotefoams reported steady trading momentum in Q3 2025, with revenue aligning with expectations despite regional variations. The company is making significant strategic advancements, including partnerships and facility developments in Asia, which are expected to bolster its long-term growth and market opportunities. The Board remains confident in achieving mid-single-digit growth for the year, supported by a strong order book and strategic initiatives.
Zotefoams has announced the appointment of Jack Clarke as an independent Non-Executive Director, effective from October 28, 2025. Clarke, who brings extensive experience from his previous roles as CFO at Essentra plc and Marshalls plc, will also chair the Audit Committee following Doug Robertson’s retirement at the end of the year. This strategic leadership change aims to bolster Zotefoams’ board with Clarke’s international strategy and finance expertise, aligning with the company’s sustainable growth objectives.
Zotefoams plc announced that directors and key managerial personnel have acquired ordinary shares under the company’s Share Incentive Plan. This transaction, compliant with UK Market Abuse Regulation, reflects the company’s commitment to aligning management interests with shareholder value, potentially reinforcing stakeholder confidence.
Zotefoams plc announced that directors and persons discharging managerial responsibilities have acquired ordinary shares under the company’s Share Incentive Plan through a dividend reinvestment program. This transaction, compliant with the UK Market Abuse Regulation, reflects ongoing engagement and investment by the company’s leadership, potentially reinforcing stakeholder confidence and aligning management interests with shareholder value.
Zotefoams plc announced that directors and persons with managerial responsibilities have acquired shares through the company’s Share Incentive Plan dividend reinvestment program. This transaction reflects the company’s ongoing commitment to aligning management interests with shareholder value, potentially enhancing stakeholder confidence and reinforcing its market position.
Zotefoams plc announced that its Group CFO, Mr. G C McGrath, acquired 20,154 ordinary shares through the vesting of a nil-cost award under the company’s Long Term Incentive Plan (LTIP) from 2020. To cover the tax liability from this vesting, Mr. McGrath sold 10,376 shares at £4.029 each and retained 11,655 shares. This transaction reflects the completion of a performance and holding period requirement, highlighting the company’s adherence to its incentive plan and potentially impacting shareholder perceptions and market confidence.
Zotefoams has announced the appointment of Nick Wright as the new Chief Financial Officer, effective from November 1, 2025, following the retirement of Gary McGrath. This leadership change is expected to support Zotefoams’ strategic objectives and strengthen its position in the global foam technology market.
Zotefoams plc announced that its directors and persons discharging managerial responsibilities have acquired shares under the company’s Share Incentive Plan. This move, involving the purchase of partnership shares and allocation of matching shares, underscores the company’s commitment to aligning management interests with shareholder value. The transactions were conducted in compliance with the UK Market Abuse Regulation, reflecting transparency and adherence to regulatory standards.